Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk

Dayeh, Tasnim LU ; Tuomi, Tiinamaija LU orcid ; Almgren, Peter LU ; Perfilyev, Alexander LU orcid ; Jansson, Per Anders ; de Mello, Vanessa D. ; Pihlajamäki, Jussi ; Vaag, Allan LU ; Groop, Leif LU and Nilsson, Emma LU , et al. (2016) In Epigenetics 11(7). p.482-488
Abstract

Identification of subjects with a high risk of developing type 2 diabetes (T2D) is fundamental for prevention of the disease. Consequently, it is essential to search for new biomarkers that can improve the prediction of T2D. The aim of this study was to examine whether 5 DNA methylation loci in blood DNA (ABCG1, PHOSPHO1, SOCS3, SREBF1, and TXNIP), recently reported to be associated with T2D, might predict future T2D in subjects from the Botnia prospective study. We also tested if these CpG sites exhibit altered DNA methylation in human pancreatic islets, liver, adipose tissue, and skeletal muscle from diabetic vs. non-diabetic subjects. DNA methylation at the ABCG1 locus cg06500161 in blood DNA was associated with an increased risk for... (More)

Identification of subjects with a high risk of developing type 2 diabetes (T2D) is fundamental for prevention of the disease. Consequently, it is essential to search for new biomarkers that can improve the prediction of T2D. The aim of this study was to examine whether 5 DNA methylation loci in blood DNA (ABCG1, PHOSPHO1, SOCS3, SREBF1, and TXNIP), recently reported to be associated with T2D, might predict future T2D in subjects from the Botnia prospective study. We also tested if these CpG sites exhibit altered DNA methylation in human pancreatic islets, liver, adipose tissue, and skeletal muscle from diabetic vs. non-diabetic subjects. DNA methylation at the ABCG1 locus cg06500161 in blood DNA was associated with an increased risk for future T2D (OR = 1.09, 95% CI = 1.02–1.16, P-value = 0.007, Q-value = 0.018), while DNA methylation at the PHOSPHO1 locus cg02650017 in blood DNA was associated with a decreased risk for future T2D (OR = 0.85, 95% CI = 0.75–0.95, P-value = 0.006, Q-value = 0.018) after adjustment for age, gender, fasting glucose, and family relation. Furthermore, the level of DNA methylation at the ABCG1 locus cg06500161 in blood DNA correlated positively with BMI, HbA1c, fasting insulin, and triglyceride levels, and was increased in adipose tissue and blood from the diabetic twin among monozygotic twin pairs discordant for T2D. DNA methylation at the PHOSPHO1 locus cg02650017 in blood correlated positively with HDL levels, and was decreased in skeletal muscle from diabetic vs. non-diabetic monozygotic twins. DNA methylation of cg18181703 (SOCS3), cg11024682 (SREBF1), and cg19693031 (TXNIP) was not associated with future T2D risk in subjects from the Botnia prospective study.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
ABCG1, adipose tissue, blood, DNA methylation, epigenetics, liver, pancreatic islets, PHOSPHO1, skeletal muscle, type 2 diabetes
in
Epigenetics
volume
11
issue
7
pages
7 pages
publisher
Landes Bioscience
external identifiers
  • pmid:27148772
  • wos:000380906200002
  • scopus:84973622879
ISSN
1559-2294
DOI
10.1080/15592294.2016.1178418
language
English
LU publication?
yes
id
87be88fb-5546-421c-b3d0-c3ab1716ee0c
date added to LUP
2017-01-16 13:44:07
date last changed
2024-04-19 18:03:29
@article{87be88fb-5546-421c-b3d0-c3ab1716ee0c,
  abstract     = {{<p>Identification of subjects with a high risk of developing type 2 diabetes (T2D) is fundamental for prevention of the disease. Consequently, it is essential to search for new biomarkers that can improve the prediction of T2D. The aim of this study was to examine whether 5 DNA methylation loci in blood DNA (ABCG1, PHOSPHO1, SOCS3, SREBF1, and TXNIP), recently reported to be associated with T2D, might predict future T2D in subjects from the Botnia prospective study. We also tested if these CpG sites exhibit altered DNA methylation in human pancreatic islets, liver, adipose tissue, and skeletal muscle from diabetic vs. non-diabetic subjects. DNA methylation at the ABCG1 locus cg06500161 in blood DNA was associated with an increased risk for future T2D (OR = 1.09, 95% CI = 1.02–1.16, P-value = 0.007, Q-value = 0.018), while DNA methylation at the PHOSPHO1 locus cg02650017 in blood DNA was associated with a decreased risk for future T2D (OR = 0.85, 95% CI = 0.75–0.95, P-value = 0.006, Q-value = 0.018) after adjustment for age, gender, fasting glucose, and family relation. Furthermore, the level of DNA methylation at the ABCG1 locus cg06500161 in blood DNA correlated positively with BMI, HbA1c, fasting insulin, and triglyceride levels, and was increased in adipose tissue and blood from the diabetic twin among monozygotic twin pairs discordant for T2D. DNA methylation at the PHOSPHO1 locus cg02650017 in blood correlated positively with HDL levels, and was decreased in skeletal muscle from diabetic vs. non-diabetic monozygotic twins. DNA methylation of cg18181703 (SOCS3), cg11024682 (SREBF1), and cg19693031 (TXNIP) was not associated with future T2D risk in subjects from the Botnia prospective study.</p>}},
  author       = {{Dayeh, Tasnim and Tuomi, Tiinamaija and Almgren, Peter and Perfilyev, Alexander and Jansson, Per Anders and de Mello, Vanessa D. and Pihlajamäki, Jussi and Vaag, Allan and Groop, Leif and Nilsson, Emma and Ling, Charlotte}},
  issn         = {{1559-2294}},
  keywords     = {{ABCG1; adipose tissue; blood; DNA methylation; epigenetics; liver; pancreatic islets; PHOSPHO1; skeletal muscle; type 2 diabetes}},
  language     = {{eng}},
  month        = {{07}},
  number       = {{7}},
  pages        = {{482--488}},
  publisher    = {{Landes Bioscience}},
  series       = {{Epigenetics}},
  title        = {{DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk}},
  url          = {{http://dx.doi.org/10.1080/15592294.2016.1178418}},
  doi          = {{10.1080/15592294.2016.1178418}},
  volume       = {{11}},
  year         = {{2016}},
}